Introduction
============

In contrast to a variety of established traditional and emerging risk factors, only a few reports concern ischaemic stroke occurrence after vaccination \[[@R1]-[@R5]\]. This rarity of association is criticized for the reliability and validity of a causal relation between vascular events and vaccination, particularly when the frequency of ischaemic stroke and myocardial infarction does not increase shortly after vaccination with the influenza vaccine \[[@R6]\]. Ambivalence arises when vaccination causes an inflammatory reaction that emphasizes an emerging stroke risk factor on one hand, and a low frequency of ischaemic stroke occurs after vaccination on the other hand.

In this study, we report a patient who suffered ischaemic stroke shortly after influenza A1/H1N1 vaccination. In order to elucidate whether a risk factor is present for ischaemic stroke in vaccination, we extracted data from the Vaccine Adverse Event Reporting System (VAERS), Department of Health and Human Services, United States of America \[[@R7]\], and reviewed previous reports of vaccination-related ischaemic stroke.

Case report
===========

A 75-year-old man received influenza A/H1N1 vaccination at 10 a.m. on one day. He then went home by motorcycle, cooked and finished lunch, completed house work, and then napped at noon. He usually woke up before 2 pm. On that day, he woke up at 5 pm and experienced dizziness, asthenia, unsteady gait with deviation to the left side, and inability to hold objects by hand properly. These discomforts lasted for 30 min and then spontaneously subsided except for asthenia. He denied any association except generalized perspiration during the attack. Similar episodes recurred 3 to 4 times daily afterwards. Each attack lasted for 10-30 min and then completely recovered. He visited our emergency service 7 days later. He had had a history of hypertension and old cerebral infarction, but only received amlodipine besylate without aspirin for prophylaxis. He lived independently. He denied having foreign travel, craniofacial trauma, flu or infection, unknown drug usage, intoxication, or consumption of herbs, alcohol or cigarettes recently.

On presentation, his vital signs were stable. Physical examination was unremarkable. Neurological examination showed normal speech, higher cortical function, neuro-ophthalmology, cranial nerves, motor system, and sensory function, except for mild intentional tremor of both hands. Cerebellar lesion was interpreted. A stroke risk factor survey, including biochemistry, haematology, lipid profiles, urinalysis, coagulation time, lupus study, antiphospholipid antibodies, immunology, coagulation function, and infection index, was within the reference range, except for hypertriglyceridaemia (260 mg%; normal: 40-160 mg%). Head magnetic resonance imaging showed high DWI and low ADC intensities scattered at the left cerebellum, compatible with new infarctions, within the vascular territory of the posterior inferior cerebellar artery (Figures [1A-B](#F1){ref-type="fig"}). Magnetic resonance arteriogram revealed basilar artery stenosis (Figure [1C](#F1){ref-type="fig"}). Nerve conduction velocity study did not disclose abnormal findings of peripheral nerves. Left cerebellar infarction was established. Aspirin and nifedipine OROS were prescribed for stroke prevention. He was discharged 6 days later with complete recovery of neurological deficits.

Discussion
==========

Neurological deficit was found 7 h after influenza A/H1N1 vaccination in our patient. However, the exact time of onset is actually unknown as he fell asleep unusually for 5 h. The causal relation between vaccination and ischaemic stroke is seriously challenged, similar to previous reports \[[@R1]-[@R5]\], especially when our patient does have a few stroke risk factors, such as hypertension, previous stroke, intracranial atherosclerosis, old age, and hypertriglyceridaemia. Our patient's infarction is compatible with small- to medium-size artery occlusion which is also seen in other ischaemic stroke patients after vaccination \[[@R2], [@R5]\] or vaccination-related angiopathy \[[@R8]\]. Nevertheless, our aim is to highlight a possibility of an underestimation of vascular complications in vaccination, and that would jeopardize an individual who exhibits multiple stroke risk factors as our patient.

Reviewing the literature from PUBMED and BIOSIS, ischaemic stroke has only been reported after vaccination of varicella-zoster virus vaccine \[[@R2], [@R4]\], influenza virus vaccine \[[@R5]\], human papillomavirus vaccine \[[@R3]\], cholera and typhoid vaccine \[[@R1]\], and also HER-2/neu-pulsed dendritic cell vaccine. According to the VAERS \[[@R7]\], the leading vaccine reported to be complicated with ischaemic stroke is seasonal flu, followed by hepatitis A and B virus, pneumococcus, diphtheria/pertussis/tetanus toxoid, poliomyelitis, and *Haemophilus influenzae*(Figure [2](#F2){ref-type="fig"}). There are a total of 18 individuals having ischaemic stroke after influenza A/H1N1 vaccination, compared to 164 individuals after seasonal flu vaccination. However, it is the first time of worldwide vaccination with influenza A/H1N1 vaccine. This indicates that ischaemic stroke is not an extremely scarce complication after vaccination. On the other hand, there is only 1 patient who had ischaemic stroke after influenza A/H1N1 vaccination in the United Kingdom \[[@R9]\]. Bias may come from the nature of the reporting system. Nevertheless, it still provides noteworthy resource data to elucidate the trend of frequency and demography of adverse reactions after influenza A/H1N1 vaccination.

Is there any risk factor for ischaemic stroke in vaccination? In fact, statistical analysis is impossible for comparison as the patient sampling from the population is too small. Approximately 38% and 61% of ischaemic stroke subjects are over 60 years after influenza A/H1N1 and seasonal flu vaccination, respectively (Figure [3](#F3){ref-type="fig"}) \[[@R7]\]. The frequency of ischaemic stroke does not significantly increase in children after varicella-zoster virus vaccination \[[@R4]\]. However, nearly half of ischaemic stroke children have concomitant stroke risk factors, such as cardiac diseases, autoimmunity disorders, vasculopathy, or coagulopathy \[[@R2]-[@R5]\]. Therefore, vaccination may promote a pre-existing prothrombotic condition. Accordingly, vaccination should be carefully evaluated and monitored in individuals associated with old age or stroke risk factors.

Vaccination can induce inflammatory and immunological responses. A flare-up of lupus has been reported \[[@R10]\]. A generation of temporary inflammatory reactions with an elevation of cytokines after vaccination with *Salmonella typhi*vaccine, increase of blood antiphospholipid antibodies with influenza vaccine, and vasculitis with a couple of vaccines have been identified. In our patient, we did not detect an abnormal alteration of immune and coagulation function or angiopathy, but that does not completely exclude their participation.

In contrast to a lucid period at least 2 to 9 days for vasculitis and longer in other autoimmune reactions, a rapid onset of symptomatic thrombosis may indicate a hypersensitive reaction in our patients. In fact, ischaemic stroke occurs within the first day in 22% and 18% of subjects receiving vaccination with influenza A/H1N1 and seasonal flu vaccine, respectively \[[@R7]\]. Although it is uncertain if an enhancement of inflammatory/immunological activity after vaccination is sufficient for initiating symptomatic vascular occlusion, the risk of an additional prothrombotic effect should be included for consideration of the vaccine programme in future.
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